|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/00 | |||
| C07K 16/24 |
| (11) | Patento numeris | 3180357 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15748249.8 |
| Europos patento paraiškos padavimo data | 2015-08-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-06-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-07-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/068404 |
| Data | 2015-08-11 |
| (87) | Numeris | WO 2016/023875 |
| Data | 2016-02-18 |
| (30) | Numeris | Data | Šalis |
| 14181067 | 2014-08-14 | EP | |
| 15159611 | 2015-03-18 | EP |
| (72) |
CORSE, Emily Rana, CH
FREYTAG, Olivier, CH
GERDES, Christian, CH
LE CLECH, Marine, CH
LEVITSKY, Hyam, US
OTT, Marion, CH
STERN, Martin, CH
WEI, Xu, CH
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | COMBINATION THERAPY OF ANTIBODIES ACTIVATING HUMAN CD40 AND ANTIBODIES AGAINST HUMAN PD-L1 |
| COMBINATION THERAPY OF ANTIBODIES ACTIVATING HUMAN CD40 AND ANTIBODIES AGAINST HUMAN PD-L1 |